CMS doesn't just "go away". If you are worried about reduced compensation, that is a legitimate concern. Reimbursement only indirectly impacts ICAD though, so the question is to what extent will derm groups stop buying machines if reimbursement is reduced. My guess-the impact won't be dramatic. It will still be high relative to the alternative, and it's a selling point to attract patients.
-The line about Peugeot no longer needing funding is BS, but the sale is directly related to the Dongfeng investment.
-Getting out of Australia is probably smart.
-Selling Ally is fairly telling of what kind of shape Ally is in.
If you want a conspiracy, find the logic behind giving up on Chevy in Europe. Akerson was pushing the 'Global Brand' concept for years.
Why do you care how many shares you have? Besides a small increase in liquidity, what difference is there between 10 shares at $1 and 1 share at $10?
The number of authorized shares also underwent a 5:1 split.
Looking at the balance sheet and cash flow, how does this company not go bankrupt or issue a massive number of shares over the next 18 months?
What do you like about ISRG? I'm familiar with the Da Vinci only in a clinical setting, and know little about the business model. Does it generate significant recurring revenue?
Besides patients wanting it because they don't know any better, it only seems to be useful in a subset of surgical applications.
I think bringing up the lawsuit is a fair point, and while I'm also long iCAD,
The tungsten lawsuit has been ongoing for quite a while. The number of cases performed with the old shield (that shed tungsten) is limited, and the harm done is questionable (i.e. the tungsten absolutely disrupts mammography, but harm to the patient in the direct sense is unknown).
Seeing as the shield is no longer in use, this particular issue has limited downside. The scarier issue would be poor results in a long-term clinical trial in either breast or skin treatment.
Does hyping stocks on Yahoo still work? I thought that went out of style circa 2003.
There was a presentation at the LD micro conference. Micro Cap + Small Float = Large Price Swings. Maybe it drops back this week, maybe it does not.
Just because something does not pop up in Yahoo News the day of a pop does not mean there is "no news" however. If you trade frequently enough to worry about short term profit taking, you really can't afford to be this lazy.
If somebody could please explain, are GM's pension benefits fixed, or indexed to inflation? Given the level of (under)funding, this obviously has huge implications on future cash flow.
Do you all think you would feel the same way if you were in the lower tier wage scale? Things are still hard enough that it won't tear things apart, but if (when) the economy picks up that system and RTW is a path to doom.
Pick any kind of multiple you want. The markets respect TSLA much more than 3-4x GM.
I'm currently long GM, so this is not a reflection of the "new" GM.
My response merely pointed out that investors were not given the opportunity to make any money back.
I am not familiar with how the warrants were valued to reimburse lenders, but let's be honest, the bond holders were royally screwed.
Finally, if you can say with a straight face that the retirees and current employees didn't make out like bandits at everyone else's expense, you, my friend, are delusional.
How else should one interpret buying just before earnings b/c you thought earnings would be strong. Personally, I think you'll do find being long the stock, but your original post made it sound like a trade. Don't be shocked if there is some pain over the next few months.
I thought you bought them b/c you expected strong earnings. Be honest, you bought them b/c the stock soared and you thought it was easy money.
It sounds sarcastic, but that is seriously how the call is going to go. I'm glad to see you did some due diligence before picking up those shares.